Scarica l'app Stockscreener
1.86
7.51%
0.13
Pre-mercato:
1.92
0.06
+3.23%
Precedente Chiudi:
$1.73
Aprire:
$1.73
Volume 24 ore:
110.91K
Relative Volume:
0.03
Capitalizzazione di mercato:
$54.92M
Reddito:
$1.93M
Utile/perdita netta:
$-3.10M
Rapporto P/E:
-0.1137
EPS:
-16.3657
Flusso di cassa netto:
$-1.93M
1 W Prestazione:
-11.85%
1M Prestazione:
+55.00%
6M Prestazione:
-31.84%
1 anno Prestazione:
-78.27%
Intervallo 1D:
$1.73
$1.945
Intervallo di 1 settimana:
$1.73
$2.08
Portata 52W:
$0.95
$11.92
China Sxt Pharmaceuticals Inc Stock (SXTC) Company Profile
Confronta SXTC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SXTC
China Sxt Pharmaceuticals Inc
|
1.86 | 54.92M | 1.93M | -3.10M | -1.93M | -16.37 |
|
RGC
Regencell Bioscience Holdings Ltd
|
78.00 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
161.67 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.50 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.89 | 47.60B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.89 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
China Sxt Pharmaceuticals Inc Borsa (SXTC) Ultime notizie
China SXT Pharmaceuticals issues 90 million new shares By Investing.com - Investing.com Canada
China SXT Pharmaceuticals issues 90 million new shares - Investing.com Australia
China SXT Pharmaceuticals Issues 90 Million Shares Following Warrant Exercise - TipRanks
Best Chinese Stocks To ResearchJune 6th - MarketBeat
Best Chinese Stocks To Research – June 6th - Defense World
China SXT Pharmaceuticals secures $100,000 in share sale By Investing.com - Investing.com Nigeria
China SXT Pharmaceuticals secures $100,000 in share sale - Investing.com Australia
China SXT Pharmaceuticals Completes Share Sale Agreement - TipRanks
Promising Chinese Stocks To Add to Your WatchlistMay 6th - MarketBeat
Promising Chinese Stocks To Add to Your Watchlist – May 6th - Defense World
Why ThredUp Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Aegis Capital Corp. Acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares, Inclusive of the Over-Allotment, for China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC). - The Globe and Mail
Chinese Stocks To Watch NowApril 27th - MarketBeat
Chinese Stocks To Watch TodayApril 26th - MarketBeat
There is no way China SXT Pharmaceuticals Inc (SXTC) can keep these numbers up - Sete News
Chinese Stocks To Watch Now – April 27th - Defense World
How does SXTC’s price to cash per share ratio compare in the market? - uspostnews.com
SXTC’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com
Market cap of China SXT Pharmaceuticals Inc [SXTC] reaches 31.52M – now what? - dbtnews.com
Chinese Stocks To Watch Today – April 26th - Defense World
Chinese Stocks To Watch Today – April 25th - Defense World
Promising Chinese Stocks To Keep An Eye OnApril 20th - MarketBeat
Promising Small Cap Stocks To Add to Your Watchlist – April 22nd - Defense World
Promising Penny Stocks To Watch Now – April 22nd - Defense World
Best Chinese Stocks To Follow Today – April 22nd - Defense World
3 Penny Stocks to Watch Now, 4/22/25 - TipRanks
Promising Chinese Stocks To Keep An Eye On – April 20th - Defense World
China SXT Pharmaceuticals Inc [SXTC] is -46.86% lower this YTD. Is it still time to buy? - dbtnews.com
Daily Progress: China SXT Pharmaceuticals Inc (SXTC) Gain 118.42, Closing at 2.16 - DWinneX
Top Chinese Stocks To Research – April 19th - Defense World
SXTC stock hits 52-week low at $2.31 amid sharp annual decline - Investing.com
Pre-market Movers In Healthcare Sector: CTXR, VCNX, SRNE, ITRM, RWLK… - RTTNews
China SXT Pharmaceuticals Reports Financial Results Amid Regulatory Challenges - TipRanks
China SXT Pharmaceuticals regains compliance with Nasdaq’s minimum bid price deficiency - MSN
China SXT Pharmaceuticals Optimizes Capital Structure with Warrant Exchange - TipRanks
China SXT Pharmaceuticals Regains Compliance With Nasdaq's Minimum Bid Price Requirement - Nasdaq
China SXT Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements - Nasdaq
China SXT Pharmaceuticals Has Regained Compliance with Nasdaq’s Minimum Bid Price Deficiency - GlobeNewswire
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Up 1,448.9% in February - Defense World
Stock market news: China SXT Pharmaceuticals -92.51%, TransCode Therapeutics -37.91% among biggest losers during midday trading - Business Upturn
Stock market news: China SXT Pharmaceuticals plummented by 92.58% while Wah Fu Education Group skyrocketed by 78.37% during midday trading - Business Upturn
Stock market today: China SXT Pharmaceuticals -93.05%, Comstock -90.24% among biggest losers in early trading - Business Upturn
Stock market today: China SXT Pharmaceuticals plunged by 92.61% while Wah Fu Education Group surged by 239.75% in early trading - Business Upturn
SXTC stock touches 52-week high of $3.95 amid market fluctuations - Investing.com India
China SXT Pharmaceuticals Inc (NASDAQ: SXTC) Stock Sentiment: What’s Wall Street Saying? - Stocks Register
China SXT Pharmaceuticals announces 1-for-8 share consolidation - Investing.com
China SXT Pharmaceutics, Inc. Announces 1-for-8 Share Consolidation to Regain Nasdaq Compliance - Nasdaq
China SXT Pharmaceuticals, Inc. Announces Share Consolidation - GlobeNewswire
Will SXTC's Share Consolidation Save Its Nasdaq Listing? Key Dates Revealed - StockTitan
China SXT Pharmaceuticals Announces New Securities Purchase Agreement - MSN
China SXT Pharmaceuticals, Inc. announced that it expects to receive $2.84 million in funding - Marketscreener.com
China Sxt Pharmaceuticals Inc Azioni (SXTC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):